메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

VAPORESSO Upholds the People-Oriented Movement to Bring the World Closer Through 10th Anniversary Cultural Initiatives

SHENZHEN, China, Oct. 23, 2025 -- Driven by innovation, VAPORESSO delivers cutting-edge products while building humanistic engagement with users worldwide. Marking its 10th anniversary, the brand launched two groundbreaking initiatives—VAPORESSO MEET and the World Hyper-Tour—to celebrate this milestone and share its people-oriented philosophy. Connecting in Person, Sharing Authentic MomentsIn the first half of the year, VAPORESSO hosted multiple VAPORESSO MEET events across various cities, bringing together channel partners, store owners, and users to break down barriers and en
- 김장윤(JASON KIM) 기자
- 2025-10-23 21:00
Gamehaus Holdings Inc. Files Annual Report on Form 20-F for Fiscal Year 2025

SHANGHAI, Oct. 23, 2025 -- Gamehaus Holdings Inc. ("Gamehaus" or the "Company") (Nasdaq: GMHS), a technology-driven mobile game publisher, today announced that it filed its annual report on Form 20-F (the "Annual Report") for the fiscal year ended June 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on October 23, 2025. The Annual Report can be accessed on the Company's investor relations website at https://ir.gamehaus.com/ as well as the SEC's website at https://www.sec.gov/. The Company will provide a hard copy of its Annu
- 김장윤(JASON KIM) 기자
- 2025-10-23 21:00
Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

LEHI, Utah, Oct. 23, 2025 -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational medicine ofirnoflast (HT-6184) for the treatment of Myelodysplastic Syndromes (MDS) — a group of bone marrow disorders characterized by ineffective blood cell production and a risk of progression to acute myeloid leukemia (AML). The FDA grants Orphan Drug Designation to the
- 김갑성 기자
- 2025-10-23 20:15
Thunes Enables Instant Payment Access To and From Colombia with New Real-Time Payment System Bre-B

SINGAPORE and BOGOTÁ, Colombia, Oct. 23, 2025 -- Thunes, the Smart Superhighway to move money around the world, has launched real-time cross-border payments to and from Colombia through Bre-B, the country's new national instant payment system from Banco de la República, the Central Bank of Colombia. This milestone highlights Thunes' commitment to connecting and supporting Real-Time Payment (RTP) systems worldwide and promoting financial inclusion through faster, interoperable, and affordable money movement. Adding Bre-B capabilities to its Direct Global Network is the la
- 황정호 기자
- 2025-10-23 20:11
ArisGlobal Receives Frost & Sullivan's 2025 Global Intelligent MedDRA Coding New Product Innovation Recognition for AI Leadership and Customer Impact

[ 메디채널 김갑성 기자 ] ArisGlobal is honored for its technological breakthrough in intelligent MedDRA coding that enhances accuracy, accelerates compliance workflows, and advances innovation in pharmacovigilance. SAN ANTONIO, Oct. 23, 2025 -- Frost & Sullivan is pleased to announce that ArisGlobal has received the 2025 Global New Product Innovation Recognition in the intelligent MedDRA Coding industry for its outstanding achievements in innovation, customer impact, and market leadership. This recognition highlights ArisGlobal's consistent leadership in developing technology solutions th
- 김갑성 기자
- 2025-10-23 20:05
Govee Lights Up the Miami Dolphins' Halloween Game at Hard Rock Stadium

[ 메디채널 황정호 기자 ] Immersive outdoor lighting bring team pride and Halloween spirit to life MIAMI, Oct. 23, 2025 -- Govee, a global leader in smart lighting innovation, is taking its official partnership with the Miami Dolphins to dazzling new heights. Before the Miami Dolphins matchup against the Baltimore Ravens at Hard Rock Stadium on October 30th, Govee will transform the fan experience inside the Dolphins Fan Zone with dynamic, vibrant lighting installations and activations designed to celebrate in aqua and orange. "Lighting is more than decoration. It's a way t
- 황정호 기자
- 2025-10-23 19:59
Newborn Town Achieves Nearly RMB 5 Billion in Revenue for First Three Quarters, Marking over 37% Year-on-Year Growth

HONG KONG, Oct. 23, 2025 -- Newborn Town Inc. (09911.HK), a leading global social entertainment company, released its unaudited operating data for the first three quarters of 2025. For the nine months ended 30 September 2025, the company's total revenue is estimated to reach approximately RMB 4,910 million to RMB 4,990 million, reflecting a year-on-year increase of approximately 37.6% to 39.9%. Among the total revenue, social networking business contributed approximately RMB 4,380 million to RMB 4,440 million, up approximately 34.5% to 36.4% year-on-year. The innovative business
- 김장윤(JASON KIM) 기자
- 2025-10-23 19:30
CaoCao Inc. Unlocks Cross-Border Ride-Hailing Service: One App, Six Countries, Ten Cities, Zero Hassle

HONG KONG, Oct. 23, 2025 -- Recently, CaoCao Inc. ('CaoCao' or 'Company' , stock code: 2643.HK) released an overseas ride-hailing guide and launched overseas mobility services in multiple countries and regions. The service initially covers 10 popular tourist cities across 6 countries—Singapore, South Korea, Malaysia, Thailand, the Philippines, and Vietnam, as well as Hong Kong SAR. This means Chinese domestic users no longer need to download additional local ride-hailing apps; they can directly hail taxis overseas via the CaoCao mobility app, which significantly simplifies the overseas travel
- 김장윤(JASON KIM) 기자
- 2025-10-23 19:11
TLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging

MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today welcomes updated guidelines from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Nuclear Medicine (EANM) and The American College of Nuclear Medicine (ACNM) that, for the first time, include the use of Telix's investigational PET[1] agent, TLX250-CDx (Zircaix®[2], 89Zr-DFO-girentuximab), for molecular imaging of renal masses. Published on the SNMMI website[3] and in The Journal of Nucl
- 김갑성 기자
- 2025-10-23 19:00
Medison Strengthens its Global Commercialization Platform, Appoints Francis Wan as VP, GM Asia Pacific

With a strong track record across APAC, Francis Wan's appointment marks a powerful acceleration of Medison's growth in the region ZUG, Switzerland, Oct. 23, 2025 -- Medison, the creator of a first-of-its-kind unified global commercialization platform for breakthrough therapies, today announced the appointment of Francis Wan as VP, GM Asia Pacific (APAC) and member of the company's Global Leadership Team. Francis will lead Medison's strategy and operations across the APAC region, a critical growth area for the company's platform. With more than 20 years of biopha
- 김갑성 기자
- 2025-10-23 19:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-10-29_WED

2025-10-28_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 29일 02시 40분